|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
1R01CA148966-01
|
$832,203
|
$832,203
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-38S2
|
$100,000
|
$6,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-38
|
$3,927,232
|
$235,634
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Community Clinical Oncology Program
|
2U10CA037422-23
|
$4,179,081
|
$334,326
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S2
|
$28,500
|
$2,280
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S3
|
$1,208,966
|
$96,717
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
High Throughput Screens of Novel Radiation Sensitizers and Protectors
|
5R01CA124635-03
|
$298,889
|
$149,445
|
Morgan, William
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$36,896
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-16
|
$2,300,000
|
$460,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$39,002
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
A metabolic role for PML in tumor suppression
|
1R01CA142780-01
|
$360,359
|
$90,090
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
1U10CA139519-01A1
|
$706,684
|
$56,535
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
2U10CA037447-26
|
$2,316,114
|
$185,289
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing disease and treatment response in colon cancer chemoprevention
|
5K05CA131504-03
|
$163,042
|
$163,042
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
2R01CA047988-19A2
|
$848,006
|
$848,006
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-05S2
|
$500,000
|
$100,000
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
5R01CA097193-09
|
$1,636,136
|
$1,636,136
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as Targets for Cancer Prevention
|
5R01CA080946-11
|
$291,038
|
$291,038
|
Gladyshev, Vadim
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
2P01CA087969-11
|
$5,136,607
|
$359,562
|
HANKINSON, SUSAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mouse Models for Human Cancer
|
5U01CA084301-12
|
$749,022
|
$112,353
|
KUCHERLAPATI, RAJU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-02
|
$1,459,614
|
$1,459,614
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Timing of Exposure to Selenium and Isoflavones and Prostate Cancer Prevention
|
1R15CA141385-01A1
|
$225,000
|
$225,000
|
CHRISTENSEN, MERRILL
|
BRIGHAM YOUNG UNIVERSITY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-27
|
$821,099
|
$65,688
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Identification of the molecular mechanism of a potent chemopreventive agent, CDDO
|
5F31CA134211-02
|
$40,679
|
$40,679
|
Gatbonton, Tonibelle
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S1
|
$100,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S2
|
$72,416
|
$1,448
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S3
|
$100,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S4
|
$50,000
|
$1,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-13
|
$691,663
|
$69,166
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-21
|
$5,104,400
|
$102,088
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of Prostate Cancer Chemoprevention by Apigenin
|
2R01CA108512-06A1
|
$246,185
|
$246,185
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of GSTP1 Reactivation by Green Tea Polyphenols
|
5R01CA115491-04
|
$264,195
|
$264,195
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT
|
N02CN433011-007
|
$1,270,503
|
$1,270,503
|
SIGMAN, CAROLINE
|
CCS ASSOCIATES INC:1109683
|
|
TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT
|
N02CN433015-009
|
$2,353,795
|
$2,353,795
|
SIGMAN, CAROLINE
|
CCS ASSOCIATES INC:1109683
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-21
|
$209,928
|
$16,794
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention
|
1R01CA142879-01A1
|
$333,038
|
$333,038
|
Epstein, Ervin
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
5R01CA129438-04
|
$304,190
|
$76,048
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$96,216
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
3P30CA033572-27S1
|
$94,753
|
$3,790
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S2
|
$100,000
|
$4,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S3
|
$101,205
|
$4,048
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S4
|
$151,808
|
$6,072
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-27
|
$2,318,695
|
$92,748
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
|
1R01CA140245-01A1
|
$709,292
|
$709,292
|
PALOMARES, MELANIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Synergistic anticancer effects of docosahexanoic acid and curcumin
|
5R03CA137765-02
|
$67,500
|
$67,500
|
Siddiqui, Rafat
|
CLARIAN HEALTH PARTNERS, INC.
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-15
|
$959,745
|
$76,780
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention
|
1R03CA150070-01
|
$73,500
|
$73,500
|
Ryan, Elizabeth
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-12
|
$729,463
|
$364,732
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
5U01CA141535-02
|
$415,242
|
$415,242
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$6,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Chemoprevention for this search: $135,897,018
|